---
title: Ivabradine
date: 2024-01-01
---
# Ivabradine


Reasonable if EF ≤35%, NYHA II or III, HR ≥70, NSR on max bB.

18% ↓ CV mort or HF hosp (Lancet 2010;376:875)
